BPA for arcalyst
Active Awarded Last action
- Contract number
- 36E79722A0008
- Awardee
-
Kiniksa Pharmaceuticals (Uk), LTD. UEI HBHWNLNMHSV5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 99% complete
- IDV ceiling
- $5,900,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement, awarded as a single-award indefinite delivery vehicle, establishes a $5.9 million contract between the Department of Veterans Affairs (VA) National Acquisition Center and Kiniksa Pharmaceuticals (UK), LTD. for the supply of Arcalyst (Rilonacept), a 220 milligram per vial injectable pharmaceutical product. The contract became effective November 10, 2021, with an ultimate completion date of November 9, 2026, and was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with no set-aside designation applied. Arcalyst is utilized in the treatment of chronic inflammatory disorders, including recurrent pericarditis and cryopyrin-associated periodic syndromes, supporting the VA's healthcare mission across multiple Veterans Integrated Service Networks and medical facilities.
The BPA mechanism enables the VA to issue task orders for pharmaceutical supplies throughout the performance period, streamlining procurement processes and ensuring continuous availability of this specialized injectable medication for eligible veteran populations. Task orders issued under this agreement have been distributed across VA facilities within multiple geographic regions, with values historically ranging from approximately $15,000 to over $190,000 per order. As the sole awardee under this BPA, Kiniksa Pharmaceuticals maintains performance locations in both the United Kingdom and the United States, with active System for Award Management registration. This indefinite delivery vehicle complements Kiniksa's concurrent $700,000 Federal Supply Schedule contract and facilitates standardized pharmaceutical procurement to support critical healthcare delivery obligations within the VA healthcare system.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 11
Quick answers
Who was awarded contract 36E79722A0008?
36E79722A0008 was awarded to Kiniksa Pharmaceuticals (Uk), LTD. by National Acquisition Center (Headquarters) on November 10, 2021.
How much is contract 36E79722A0008 worth?
36E79722A0008's own ceiling is $5,900,000.
Who can order from contract 36E79722A0008?
36E79722A0008 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79722A0008 under another contract?
Yes. 36E79722A0008 is a blanket purchase agreement under 36F79722D0002, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79722A0008 competed?
The extent of competition for 36E79722A0008 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV